home

clinical

genetic-testing

Clinical

 and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

Articles

An oral abstract presentation at SMFM’s 42nd Annual Pregnancy Meeting explored cfDNA testing and participants’ knowledge and willingness of genetic data sharing.

Prenatal genetic data sharing and privacy risks

A recent study suggests that unconscious or implicit bias may exist when it comes to physicians referring African American patients with breast cancer for genetic counseling and testing. 

New study shows racial disparities in genetic testing referrals for women

Genomic testing has grown in importance as the number of targeted anticancer therapies rises. Early genomic testing can help to guide treatment choices.

Overcoming barriers to genomic testing in community care settings

CRISPR gene-editing technology holds the potential to usher in a new age in medicine, according to a featured speaker at the North American Menopause Society Annual Meeting, being held this week in Washington, D.C.

Gene-editing technology: potential to usher in a new age in medicine

You can reach her a lcarr@mjhlifesciences.com.

A new study in The New England Journal of Medicine used exome sequencing to analyze 127 fetuses with unexplained cases of nonimmune Hydrops fetalis.

DNA sequencing technique may help prenatally detect NIHF 

A new report in Pediatrics investigated whether black children were likely to have more complications and greater mortality following surgery than their white peers. 

Racial disparities in healthcare impact post-surgery outcomes

During a routine office visit, a patient mentions that she recently submitted a saliva sample to 23andMe. The company performed BRCA analysis and the patient wants to discuss the results with you. How should you approach the discussion?

Managing BRCA results from 23andMe

A new study suggests that polycystic ovary syndrome (PCOS) may be linked to the epidermal growth factor receptor (EGFR) and the Hippo pathways.

Genetic associations with PCOS

Guidelines from the National Comprehensive Cancer Network (NCCN) list seven criteria for genetic testing in women with breast cancer.

Genetic testing for BRCA: Which NCCN criteria tell the tale?

This quiz reviews some of the major takeaways from the February 2019 article, New tools for counseling on prenatal genetic testing.

Genetic Testing